Literature DB >> 28948492

Significant Hydrolysis of Wheat Gliadin by Bacillus tequilensis (10bT/HQ223107): a Pilot Study.

Sandip K Wagh1, Praful P Gadge1, Manohar V Padul2.   

Abstract

Peptidase therapy is suggested to be effective to minimize gliadin toxicity in celiac disease (CD). Hence, present study deals with gliadin-hydrolysing peptidases. The efficient peptidase from the Bacillus tequilensis was purified using ammonium sulfate fractionation and preparative electrophoresis. Analysis of in-solution and in-gel hydrolysis of gliadin using one and two-dimensional SDS-PAGE revealed nearly complete hydrolysis of gliadin peptides after 180 min of incubation with B. tequilensis protease. Purified peptidase was found to be stable at acidic (pH 3.5) to neutral (pH 7.2) pH range. The molecular mass and isoelectric point of the peptidase were observed around 29 kDa and 5.2, respectively. The internal protein sequence obtained through mass spectrometric analysis suggested that peptidase might belong to peptidase S9 family known for prolyl-specific peptidases. This study recommends the possible applicability of this peptidase for elimination of immunotoxic gliadin peptides and may prove useful in CD treatment.

Entities:  

Keywords:  2D electrophoresis; Celiac disease; Gliadin hydrolysis; Zymography

Mesh:

Substances:

Year:  2018        PMID: 28948492     DOI: 10.1007/s12602-017-9331-5

Source DB:  PubMed          Journal:  Probiotics Antimicrob Proteins        ISSN: 1867-1306            Impact factor:   4.609


  36 in total

Review 1.  Alkaliphiles: some applications of their products for biotechnology.

Authors:  K Horikoshi
Journal:  Microbiol Mol Biol Rev       Date:  1999-12       Impact factor: 11.056

Review 2.  The role of enzyme supplementation in digestive disorders.

Authors:  Mario Roxas
Journal:  Altern Med Rev       Date:  2008-12

3.  The neighbor-joining method: a new method for reconstructing phylogenetic trees.

Authors:  N Saitou; M Nei
Journal:  Mol Biol Evol       Date:  1987-07       Impact factor: 16.240

Review 4.  Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease.

Authors:  Tamara Matysiak-Budnik; Celine Candalh; Christophe Cellier; Christophe Dugave; Abdelkader Namane; Teresita Vidal-Martinez; Nadine Cerf-Bensussan; Martine Heyman
Journal:  Gastroenterology       Date:  2005-09       Impact factor: 22.682

5.  Identification and characterization of intestinal lactobacilli strains capable of degrading immunotoxic peptides present in gluten.

Authors:  R M Duar; K J Clark; P B Patil; C Hernández; S Brüning; T E Burkey; N Madayiputhiya; S L Taylor; J Walter
Journal:  J Appl Microbiol       Date:  2014-12-18       Impact factor: 3.772

6.  Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease.

Authors:  Dariusz Stepniak; Liesbeth Spaenij-Dekking; Cristina Mitea; Martine Moester; Arnoud de Ru; Renee Baak-Pablo; Peter van Veelen; Luppo Edens; Frits Koning
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-05-11       Impact factor: 4.052

7.  A bifunctional α-amylase/trypsin inhibitor from pigeonpea seeds: Purification, biochemical characterization and its bio-efficacy against Helicoverpa armigera.

Authors:  Prafull P Gadge; Sandip K Wagh; Faiyaz K Shaikh; Rajesh D Tak; Manohar V Padul; Manvendra S Kachole
Journal:  Pestic Biochem Physiol       Date:  2015-06-20       Impact factor: 3.963

Review 8.  Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling.

Authors:  Emily G Severance; Robert H Yolken; William W Eaton
Journal:  Schizophr Res       Date:  2014-07-15       Impact factor: 4.939

9.  Prevalence of Celiac disease among children in Finland.

Authors:  Markku Mäki; Kirsi Mustalahti; Jorma Kokkonen; Petri Kulmala; Mila Haapalahti; Tuomo Karttunen; Jorma Ilonen; Kaija Laurila; Ingrid Dahlbom; Tony Hansson; Peter Höpfl; Mikael Knip
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

10.  Discovery of a novel and rich source of gluten-degrading microbial enzymes in the oral cavity.

Authors:  Eva J Helmerhorst; Maram Zamakhchari; Detlef Schuppan; Frank G Oppenheim
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.240

View more
  2 in total

Review 1.  Celiac Disease and Possible Dietary Interventions: From Enzymes and Probiotics to Postbiotics and Viruses.

Authors:  Sandip K Wagh; Karen M Lammers; Manohar V Padul; Alfonso Rodriguez-Herrera; Veronica I Dodero
Journal:  Int J Mol Sci       Date:  2022-10-04       Impact factor: 6.208

Review 2.  New Insights into Non-Dietary Treatment in Celiac Disease: Emerging Therapeutic Options.

Authors:  Verónica Segura; Ángela Ruiz-Carnicer; Carolina Sousa; María de Lourdes Moreno
Journal:  Nutrients       Date:  2021-06-23       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.